Fiacitabine

Fiacitabine

SCHEMBL6725815

Nc1nc(=O)n([C@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
ADRA1A P35348 1/20 0.50
PDE4D Q08499 1/20 0.50
PDE3A Q14432 1/20 0.50
LMNA P02545 3/20 0.49
MTOR P42345 2/20 0.49
ALDH1A1 P00352 2/20 0.49
THRB P10828 1/20 0.49
MDM2 Q00987 1/20 0.49
NCOA1 Q15788 1/20 0.49
NCOA3 Q9Y6Q9 1/20 0.49
GMNN O75496 1/20 0.49
TP53 P04637 1/20 0.49
NFKB1 P19838 1/20 0.49
DNMT1 P26358 1/20 0.49
THPO P40225 1/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fiacitabine SCHEMBL6715038 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL138935 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL773659 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL3120689 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL15630217 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL16943181 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL138934 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL1984820 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL768016 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A
Fiacitabine SCHEMBL7464079 1.00 PDE2A (0.50) PDE2AADORA3ADORA2AADORA1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677311-B1 DNA EXPRESSING AN EXOGENOUS HERPES SIMPLEX THYMIDINE KINASE ENZYME SELECTIVELY CONVERTS LATENT TOXIN INTO CELL TOXIN TO INHIBIT GROWTH OR CAUSE DEATH OF A TISSUE-TYPE OR CELL LINE THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 2004-01-13 US disclosed
EP-0010205-A1 5-Substituted 1-(2'-deoxy-2'-substituted-beta-D-arabinofuranosyl) pyrimidine nucleosides and pharmaceutical compositions containing them Sloan-Kettering Institute For Cancer Research (US) 1980-04-30 EP disclosed